Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma

Ellen J. KimUniversity of Pennsylvania, PA, USACorrespondence[email protected]

Youn H. KimStanford Cancer Center, Stanford, CA, USA

Alain H. RookUniversity of Pennsylvania, PA, USA

Adam LernerBoston Medical Center, Boston, MA, USA

Madeleine DuvicThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA

Sunil ReddyStanford Cancer Center, Stanford, CA, USA

Tadeusz RobakMedical University of Lodz, Lodz, Poland

Jürgen C. BeckerMedical University of Graz, Graz, Austria

Alexey SamtsovState Educational Institution for Higher Professional Education Military Medical Academy, Saint Petersburg, Russia

William McCullochAlba BioPharm Advisors Inc., Raleigh, NC, USA

Joel WaksmanBrightech International LLC, Somerset, NJ, USA

Sean WhittakerGuy's and St Thomas’ Hospitals, London, UK

Your download is now in progress and you may close this window